Missing Conflict of Interest Disclosure

    July 2017 in “ JAMA Dermatology
    Image of study
    TLDR The document corrects a missing conflict of interest and acknowledges a pioneer in hair transplantation and his other contributions.
    The document includes a correction regarding a missing conflict of interest disclosure for an article on the efficacy and tolerance of anti-tumor necrosis factor alpha agents in cutaneous sarcoidosis, where it was added that Dr. Chosidow received personal honorarium fees from Abbvie in 2016. Additionally, it features a notable note on Norman Orentreich, MD, who is recognized as the father of hair transplantation. Orentreich performed the first hair transplantation surgery for male pattern baldness in 1952 and later introduced the concept of 'donor dominance'. His early method of punch grafting led to a "doll's head" appearance, which was later improved upon with mini-micro grafting and follicular unit transplantation techniques that are used today. The document also mentions a correction to a misspelling of a coauthor's surname in a different article and acknowledges Orentreich's other contributions, including founding a biomedical research organization and developing the Clinique cosmetic brand.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Debunking Androgenetic Theory (Hair Transplants)

      in Research/Science  25 upvotes 1 year ago
      The post discusses a theory that hair regrowth after transplant is due to the angiogenesis process (new blood vessels forming), not because the transplanted hair is unaffected by DHT. The responses highlight the established belief in 'donor dominance' (the importance of the hair's origin in transplantation) and skepticism about the new theory.

      community Pyrilutamide cease and desist from Kintor

      in Transplants  12 upvotes 1 year ago
      Considering a hair transplant, using Pyrilutamide, the potential availability of CosmeRNA, and the significance of taking Minoxidil and Finasteride for long-term results.

      community Verteporfin and Microneedling

      in Treatments 6 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

    Similar Research

    5 / 1000+ results